Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.6679945261117224e-51,37.899937926753566,4431.26899398843,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL9', 'RPL6', 'RPL7', 'RPS15', 'RPL7A', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",6.0047802940022006e-49,0,0,56
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.512171946978441e-09,6.138461538461539,124.67042798152626,"['NDUFB9', 'ATP5PF', 'SURF1', 'COX7B', 'NDUFA7', 'NDUFB10', 'NDUFA4', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'COX7A2', 'UQCR10', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRQ', 'NDUFS6', 'UQCRFS1', 'SLC25A5']",2.7219095045611936e-07,0,0,21
3,Nonalcoholic fatty liver disease WP4396,2.2479426747281057e-07,4.173835376532399,63.89340676827144,"['NDUFB9', 'XBP1', 'COX7B', 'NDUFA7', 'TGFB1', 'NDUFB10', 'NDUFB11', 'NDUFA4', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'COX7A2', 'UQCR10', 'COX7A1', 'COX7C', 'UQCRQ', 'NDUFS6', 'DDIT3', 'LEPR', 'CYCS', 'UQCRFS1', 'BAX']",2.697531209673727e-05,0,0,22
4,Mitochondrial CIV Assembly WP4922,9.415168374596931e-06,8.408989726027396,97.31882329782742,"['COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX17', 'COX7A2', 'COX14', 'COX7C', 'PET117']",0.0008473651537137238,0,0,9
5,Cholesterol Biosynthesis Pathway WP197,6.071167174004783e-05,12.406587166382737,120.46020221558472,"['SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.004371240365283444,0,0,6
6,Allograft Rejection WP2328,0.0001478786894387829,7.670347319815298,67.64570031018026,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.008872721366326974,0,0,7
7,Oxidative phosphorylation WP623,0.00019116088681774031,4.671097770154374,39.99578486958079,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'ATP6AP1', 'NDUFB10', 'NDUFS6', 'NDUFA4', 'ATP6AP2', 'NDUFB2', 'ATP5MC1']",0.009831131322055216,0,0,10
8,Statin inhibition of cholesterol production WP430,0.0024646339528003602,9.274193548387096,55.69813530176414,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.09513757005469604,0,0,4
9,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.0026427102792971123,inf,inf,"['TGFB1', 'VIP']",0.09513757005469604,0,0,2
10,Gastric acid production WP2596,0.0026427102792971123,inf,inf,"['CCK', 'VIP']",0.09513757005469604,0,0,2
11,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0032566172022226846,3.6329372524494477,20.80607247358194,"['NDUFB9', 'NDUFA7', 'NDUFB10', 'NDUFS6', 'NDUFB11', 'NDUFB3', 'NDUFB2', 'NDUFA1']",0.10045188541423707,0,0,8
12,Vitamin D Receptor Pathway WP2877,0.003348396180474569,3.288275584206285,18.740782883854223,"['ADAMTS5', 'SFRP1', 'ABCB1', 'TGFB1', 'IGFBP5', 'GADD45A', 'PNOC', 'TIMP2', 'TIMP3']",0.10045188541423707,0,0,9
13,"GPCRs, Class A Rhodopsin-like WP455",0.0037063293362424527,3.546113146113146,19.850124683637556,"['HRH1', 'P2RY14', 'CHRM5', 'OPRK1', 'NMBR', 'HTR4', 'MCHR1', 'HCRTR2']",0.10263681238825254,0,0,8
14,Mevalonate pathway WP3963,0.004058345169078399,13.892796610169492,76.50735283009766,"['HMGCS1', 'HMGCR', 'ACAT2']",0.10435744720487312,0,0,3
15,Mitochondrial complex III assembly WP4921,0.006008493516597965,6.743015897515049,34.48770250695954,"['UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR10']",0.14054926165499942,0,0,4
16,miR-509-3p alteration of YAP1/ECM axis WP3967,0.006246633851333307,11.113220338983052,56.4075118800218,"['COL5A1', 'PBX3', 'FN1']",0.14054926165499942,0,0,3
17,ACE Inhibitor Pathway WP554,0.014792955044854818,18.495769881556683,77.93385406250799,"['TGFB1', 'ATP6AP2']",0.2958591008970963,0,0,2
18,Cytokines and Inflammatory Response WP530,0.014792955044854818,18.495769881556683,77.93385406250799,"['TGFB1', 'IL7']",0.2958591008970963,0,0,2
19,Cardiac Progenitor Differentiation WP2406,0.01739535075424451,4.633701188455008,18.77368273770432,"['MESP1', 'TGFB1', 'TNNT2', 'THY1']",0.3295961195541065,0,0,4
20,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.019570474518869577,3.0939806927881883,12.170894727961782,"['SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.3443006450165653,0,0,6
21,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.021040594973234548,6.171751412429378,23.830993685804355,"['TGFB1', 'FN1', 'IGFBP7']",0.3443006450165653,0,0,3
22,Nanomaterial induced apoptosis WP2507,0.021040594973234548,6.171751412429378,23.830993685804355,"['ENDOG', 'BAX', 'CYCS']",0.3443006450165653,0,0,3
23,Dopaminergic Neurogenesis WP2855,0.023819402390275118,12.329385222786238,46.07805415347462,"['TGFB1', 'ASCL1']",0.3633283013175055,0,0,2
24,Photodynamic therapy-induced unfolded protein response WP3613,0.024221886754500366,4.118090926240332,15.321351703692654,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9']",0.3633283013175055,0,0,4
25,Imatinib and Chronic Myeloid Leukemia WP3640,0.03225617878320042,5.0486902927580894,17.337433008293914,"['SPRED2', 'ABCB1', 'GADD45A']",0.4466240139212366,0,0,3
26,Peptide GPCRs WP24,0.03225617878320042,5.0486902927580894,17.337433008293914,"['OPRK1', 'NMBR', 'HCRTR2']",0.4466240139212366,0,0,3
27,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.038818110887534424,4.627542372881356,15.034276026684605,"['HMGCS1', 'HMGCR', 'LDLR']",0.5175748118337924,0,0,3
28,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.05144868215557664,inf,inf,['FMO5'],0.6175375347701406,0,0,1
29,Codeine and Morphine Metabolism WP1604,0.05144868215557664,inf,inf,['ABCB1'],0.6175375347701406,0,0,1
30,Sleep regulation WP3591,0.05379026016542096,3.9657384987893463,11.590516646762188,"['AHCY', 'CRH', 'HCRTR2']",0.6175375347701406,0,0,3
31,Monoamine GPCRs WP58,0.05379026016542096,3.9657384987893463,11.590516646762188,"['HRH1', 'CHRM5', 'HTR4']",0.6175375347701406,0,0,3
32,Proteasome Degradation WP183,0.05776225777364363,2.317930153321976,6.609391693789734,"['H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10']",0.6175375347701406,0,0,6
33,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.060197589283238324,6.1630005640157925,17.318789465075955,"['SFRP1', 'TGFB1']",0.6175375347701406,0,0,2
34,Matrix Metalloproteinases WP129,0.060197589283238324,6.1630005640157925,17.318789465075955,"['TIMP2', 'TIMP3']",0.6175375347701406,0,0,2
35,Endochondral Ossification with Skeletal Dysplasias WP4808,0.06287558930493578,2.5041367898510756,6.927938026449098,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3']",0.6175375347701406,0,0,5
36,Endochondral Ossification WP474,0.06287558930493578,2.5041367898510756,6.927938026449098,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3']",0.6175375347701406,0,0,5
37,Senescence and Autophagy in Cancer WP615,0.06346913551804223,2.0944897060442584,5.7749302557547395,"['TGFB1', 'MAP1LC3A', 'IGFBP5', 'FN1', 'IGFBP7', 'CXCL14', 'SLC39A3']",0.6175375347701406,0,0,7
38,Unfolded protein response WP4925,0.07110356367493063,3.469385593220339,9.171729583610686,"['XBP1', 'HSPA5', 'DDIT3']",0.6542962846385937,0,0,3
39,DNA Mismatch Repair WP531,0.07110356367493063,3.469385593220339,9.171729583610686,"['POLE4', 'RPA3', 'POLE2']",0.6542962846385937,0,0,3
40,p38 MAPK Signaling Pathway WP400,0.07269958718206597,2.7431302270011946,7.190895267895615,"['RPS6KA5', 'DDIT3', 'HSPB1', 'HMGN1']",0.6542962846385937,0,0,4
41,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.07482123435258257,5.2820884699057284,13.694625436487366,"['SFRP1', 'SST']",0.6569669357787739,0,0,2
42,Glycolysis in senescence WP5049,0.09042861816733397,4.621404399323181,11.106133584055824,"['LDHA', 'ALDOC']",0.7259786715738047,0,0,2
43,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.09042861816733397,4.621404399323181,11.106133584055824,"['HMGCS1', 'HMGCR']",0.7259786715738047,0,0,2
44,IL-18 signaling pathway WP4754,0.09231160732865037,1.5922793213671012,3.7937414460412158,"['ADAMTS5', 'ARL4D', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'FN1', 'TIMP3', 'CYCS', 'HSPB1', 'BAX', 'ITM2C']",0.7259786715738047,0,0,12
45,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.09822346576159223,1.9853370649793136,4.606994777285006,"['SQLE', 'HMGCS1', 'INSIG1', 'HMGCR', 'LDLR', 'FDFT1']",0.7259786715738047,0,0,6
46,Composition of Lipid Particles WP3601,0.1002547452261369,18.466216216216218,42.473052196015324,['LDLR'],0.7259786715738047,0,0,1
47,COVID-19 adverse outcome pathway WP4891,0.1002547452261369,18.466216216216218,42.473052196015324,['IL7'],0.7259786715738047,0,0,1
48,Drug Induction of Bile Acid Pathway WP2289,0.1002547452261369,18.466216216216218,42.473052196015324,['ABCB1'],0.7259786715738047,0,0,1
49,EV release from cardiac cells and their functional effects WP3297,0.1002547452261369,18.466216216216218,42.473052196015324,['RGS16'],0.7259786715738047,0,0,1
50,Aryl Hydrocarbon Receptor Pathway WP2873,0.10104894359752703,2.92078501338091,6.694878213819507,"['TGFB1', 'AIP', 'BAX']",0.7259786715738047,0,0,3
51,TP53 network WP1742,0.10688019331503236,4.10753901109231,9.184649299316384,"['GADD45A', 'BAX']",0.7259786715738047,0,0,2
52,Cori Cycle WP1946,0.10688019331503236,4.10753901109231,9.184649299316384,"['LDHA', 'PGAM1']",0.7259786715738047,0,0,2
53,Overview of nanoparticle effects WP3287,0.10688019331503236,4.10753901109231,9.184649299316384,"['FN1', 'BAX']",0.7259786715738047,0,0,2
54,Oncostatin M Signaling Pathway WP2374,0.11293584096834626,2.057445200302343,4.487155072048632,"['PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'LDLR']",0.736115838208597,0,0,5
55,Selenium Micronutrient Network WP15,0.12054032351179023,2.243144518186963,4.745980001674113,"['SELENOM', 'SEPHS2', 'LDLR', 'SELENOH']",0.736115838208597,0,0,4
56,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.12334209081352411,2.642130750605327,5.529434214093245,"['LDHA', 'ANGPT2', 'BAX']",0.736115838208597,0,0,3
57,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.12404812572224848,3.696446700507614,7.714800968154055,"['TGFB1', 'FN1']",0.736115838208597,0,0,2
58,Type II diabetes mellitus WP1584,0.12404812572224848,3.696446700507614,7.714800968154055,"['SURF1', 'PRKCD']",0.736115838208597,0,0,2
59,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.12404812572224848,3.696446700507614,7.714800968154055,"['CD81', 'HSPB1']",0.736115838208597,0,0,2
60,miRNA targets in ECM and membrane receptors WP2911,0.12404812572224848,3.696446700507614,7.714800968154055,"['COL5A1', 'FN1']",0.736115838208597,0,0,2
61,Pyrimidine metabolism WP4022,0.1294992671349786,1.8217666936632502,3.723836967111163,"['NT5C', 'POLE4', 'POLE2', 'POLR1C', 'POLR2I', 'POLR2K']",0.736115838208597,0,0,6
62,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.12957257954284518,2.1769699390791972,4.448668755011014,"['BEX3', 'HSPA5', 'HSPB1', 'PTK2B']",0.736115838208597,0,0,4
63,ATM Signaling Network in Development and Disease  WP3878,0.13887624436597856,2.1145767644918747,4.174538389877444,"['DCLRE1C', 'KAT5', 'HSPB1', 'HMGN1']",0.736115838208597,0,0,4
64,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.14181546209574375,3.3600984463928625,6.563040482595768,"['BAX', 'BCL2L14']",0.736115838208597,0,0,2
65,VEGFA-VEGFR2 Signaling Pathway WP3888,0.14590469198925426,1.302988387787656,2.5079942183298867,"['SET', 'TRPC3', 'TRAF3IP2', 'PRKCD', 'FN1', 'GAB1', 'HSPB1', 'RPL10A', 'APOLD1', 'RAB11A', 'RPL7', 'ACTG1', 'LDHA', 'RPS6KA5', 'RPL18A', 'RPLP2', 'DNAJB9', 'CYCS', 'PTK2B', 'IGFBP7', 'MYH11', 'RPL26']",0.736115838208597,0,0,22
66,Tgif disruption of Shh signaling WP3674,0.14655361317260204,9.232263513513514,17.72930609518177,['GLI3'],0.736115838208597,0,0,1
67,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.14655361317260204,9.232263513513514,17.72930609518177,['ABCB1'],0.736115838208597,0,0,1
68,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.14655361317260204,9.232263513513514,17.72930609518177,['BAX'],0.736115838208597,0,0,1
69,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.14655361317260204,9.232263513513514,17.72930609518177,['CD247'],0.736115838208597,0,0,1
70,Platelet-mediated interactions with vascular and circulating cells WP4462,0.14655361317260204,9.232263513513514,17.72930609518177,['TGFB1'],0.736115838208597,0,0,1
71,Base Excision Repair WP4752,0.14722316764171942,2.4119380987472367,4.620804748464923,"['POLE4', 'APEX1', 'POLE2']",0.736115838208597,0,0,3
72,Development of ureteric collection system WP5053,0.14722316764171942,2.4119380987472367,4.620804748464923,"['ETV4', 'GLI3', 'FREM2']",0.736115838208597,0,0,3
73,Apoptosis Modulation and Signaling WP1772,0.1515461570095957,1.8508503401360543,3.492304789422232,"['HRK', 'ENDOG', 'CYCS', 'BAX', 'PTPN13']",0.747350911280198,0,0,5
74,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.1582457884285009,1.999908227412472,3.6870424709584255,"['XBP1', 'MAP1LC3A', 'HSPA5', 'DDIT3']",0.7572362553014981,0,0,4
75,Glycolysis and Gluconeogenesis WP534,0.15968357729657676,2.311228813559322,4.24009039079731,"['LDHA', 'PGAM1', 'ALDOC']",0.7572362553014981,0,0,3
76,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.15986098723031628,1.814392423636121,3.3265990069543703,"['TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX']",0.7572362553014981,0,0,5
77,Striated Muscle Contraction Pathway WP383,0.17873031914618662,2.8426395939086295,4.8946763220463305,"['TNNT2', 'ACTG1']",0.8144672771218631,0,0,2
78,Type II interferon signaling (IFNG) WP619,0.17873031914618662,2.8426395939086295,4.8946763220463305,"['PRKCD', 'HLA-B']",0.8144672771218631,0,0,2
79,One-carbon metabolism WP241,0.17873031914618662,2.8426395939086295,4.8946763220463305,"['AHCY', 'CHDH']",0.8144672771218631,0,0,2
80,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.1890018708488369,1.8494057724957556,3.081106993755036,"['SFRP4', 'SFRP1', 'TCF7', 'CXXC4']",0.8163165482917292,0,0,4
81,Bile acids synthesis and enterohepatic circulation  WP4389,0.19047386126807014,6.1542792792792795,10.205273949256068,['LDLR'],0.8163165482917292,0,0,1
82,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.19047386126807014,6.1542792792792795,10.205273949256068,['FN1'],0.8163165482917292,0,0,1
83,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.19047386126807014,6.1542792792792795,10.205273949256068,['LDLR'],0.8163165482917292,0,0,1
84,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.19047386126807014,6.1542792792792795,10.205273949256068,['VEGFB'],0.8163165482917292,0,0,1
85,Zinc homeostasis WP3529,0.19769158538125067,2.639352187575538,4.278514241944977,"['SLC39A7', 'SLC39A3']",0.8180341464051752,0,0,2
86,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.19769158538125067,2.639352187575538,4.278514241944977,"['H3F3B', 'H2AFZ']",0.8180341464051752,0,0,2
87,Methionine De Novo and Salvage Pathway WP3580,0.19769158538125067,2.639352187575538,4.278514241944977,"['AHCY', 'CHDH']",0.8180341464051752,0,0,2
88,Acute viral myocarditis WP4298,0.21047707547319386,1.7610154418303825,2.7443286677080856,"['ENDOG', 'TGFB1', 'CYCS', 'BAX']",0.857980614387456,0,0,4
89,Fas ligand pathway and stress induction of heat shock proteins WP314,0.2122933176697908,1.9803268765133173,3.0690836343423507,"['HSPB1', 'CYCS', 'ACTG1']",0.857980614387456,0,0,3
90,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.21687843308127358,2.463169768753525,3.764753747211719,"['RPS6KA5', 'HTR4']",0.857980614387456,0,0,2
91,Differentiation Pathway WP2848,0.21687843308127358,2.463169768753525,3.764753747211719,"['TGFB1', 'FGF1']",0.857980614387456,0,0,2
92,Vitamin D Metabolism WP1531,0.2321374918081022,4.615287162162162,6.740282811073955,['DHCR7'],0.8796789163254398,0,0,1
93,Farnesoid X receptor pathway WP2879,0.2321374918081022,4.615287162162162,6.740282811073955,['FKBP5'],0.8796789163254398,0,0,1
94,Inflammatory Response Pathway WP453,0.2321374918081022,4.615287162162162,6.740282811073955,['FN1'],0.8796789163254398,0,0,1
95,Peroxiredoxin 2 induced ovarian failure WP4873,0.2321374918081022,4.615287162162162,6.740282811073955,['BAX'],0.8796789163254398,0,0,1
96,Ebola Virus Pathway on Host WP4217,0.24596853784312825,1.460190083385636,2.047992005181903,"['HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'ASGR1', 'ACTG1']",0.8884034096969826,0,0,6
97,Endometrial cancer WP4155,0.2552477436933166,1.6072931276297335,2.1947919749805447,"['GADD45A', 'TCF7', 'BAX', 'FGF1']",0.8884034096969826,0,0,4
98,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.2552477436933166,1.6072931276297335,2.1947919749805447,"['ANGPT2', 'FN1', 'BAX', 'ANGPTL1']",0.8884034096969826,0,0,4
99,Angiogenesis WP1539,0.255642798699898,2.1729869612819748,2.963897992286913,"['TIMP2', 'TIMP3']",0.8884034096969826,0,0,2
100,IL-7 signaling pathway WP205,0.255642798699898,2.1729869612819748,2.963897992286913,"['IL7', 'PTK2B']",0.8884034096969826,0,0,2
101,Selective expression of chemokine receptors during T-cell polarization WP4494,0.2716602619915953,3.691891891891892,4.811284700604396,['TGFB1'],0.8884034096969826,0,0,1
102,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.2716602619915953,3.691891891891892,4.811284700604396,['TCF7'],0.8884034096969826,0,0,1
103,Sulfation Biotransformation Reaction WP692,0.2716602619915953,3.691891891891892,4.811284700604396,['PAPSS2'],0.8884034096969826,0,0,1
104,Transcriptional cascade regulating adipogenesis WP4211,0.2716602619915953,3.691891891891892,4.811284700604396,['DDIT3'],0.8884034096969826,0,0,1
105,"Degradation pathway of sphingolipids, including diseases WP4153",0.2716602619915953,3.691891891891892,4.811284700604396,['NEU1'],0.8884034096969826,0,0,1
106,IL1 and megakaryocytes in obesity WP2865,0.2716602619915953,3.691891891891892,4.811284700604396,['TIMP2'],0.8884034096969826,0,0,1
107,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.2716602619915953,3.691891891891892,4.811284700604396,['AHCY'],0.8884034096969826,0,0,1
108,Endothelin Pathways WP2197,0.2750940555373481,2.052077458168829,2.6484978055156403,"['ADCY10', 'MYLK']",0.8884034096969826,0,0,2
109,Folate Metabolism WP176,0.2750940555373481,2.052077458168829,2.6484978055156403,"['AHCY', 'LDLR']",0.8884034096969826,0,0,2
110,Genes controlling nephrogenesis WP4823,0.2750940555373481,2.052077458168829,2.6484978055156403,"['ETV4', 'GLI3']",0.8884034096969826,0,0,2
111,IL-6 signaling pathway WP364,0.28216367311914675,1.6795069337442219,2.1250263375270886,"['PRKCD', 'GAB1', 'VIP']",0.8884034096969826,0,0,3
112,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.2899789698449737,1.5084716399293163,1.8674077547992098,"['SFRP4', 'SFRP1', 'TCF7', 'CXXC4']",0.8884034096969826,0,0,4
113,Breast cancer pathway WP4262,0.2901701643660098,1.3694239384188276,1.6943714696016412,"['SFRP4', 'SHC3', 'GADD45A', 'TCF7', 'BAX', 'FGF1']",0.8884034096969826,0,0,6
114,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.2945173745870984,1.943895271172856,2.376251171412156,"['HSPB1', 'RAB11A']",0.8884034096969826,0,0,2
115,Lung fibrosis WP3624,0.2945173745870984,1.943895271172856,2.376251171412156,"['TGFB1', 'FGF1']",0.8884034096969826,0,0,2
116,Thiamine metabolic pathways WP4297,0.3091520013974442,3.076295045045045,3.6113310752050727,['BCKDK'],0.8884034096969826,0,0,1
117,Cancer immunotherapy by PD-1 blockade WP4585,0.3091520013974442,3.076295045045045,3.6113310752050727,['HLA-A'],0.8884034096969826,0,0,1
118,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3091520013974442,3.076295045045045,3.6113310752050727,['DHCR7'],0.8884034096969826,0,0,1
119,Dual hijack model of Vif in HIV infection WP3300,0.3091520013974442,3.076295045045045,3.6113310752050727,['ELOB'],0.8884034096969826,0,0,1
120,HIF1A and PPARG regulation of glycolysis WP2456,0.3091520013974442,3.076295045045045,3.6113310752050727,['LDHA'],0.8884034096969826,0,0,1
121,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3091520013974442,3.076295045045045,3.6113310752050727,['TGFB1'],0.8884034096969826,0,0,1
122,Osteoclast Signaling WP12,0.3091520013974442,3.076295045045045,3.6113310752050727,['AIMP2'],0.8884034096969826,0,0,1
123,MTHFR deficiency WP4288,0.3138642162369351,1.8465313028764805,2.13975090683212,"['CHDH', 'CYCS']",0.8884034096969826,0,0,2
124,Oxysterols derived from cholesterol WP4545,0.3138642162369351,1.8465313028764805,2.13975090683212,"['INSIG1', 'DHCR7']",0.8884034096969826,0,0,2
125,Myometrial relaxation and contraction pathways WP289,0.32056703412141563,1.281113776906701,1.4574768569183885,"['PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'CRH', 'CORIN', 'ACTG1']",0.8884034096969826,0,0,7
126,Adipogenesis WP236,0.3220668966703768,1.3586684673869547,1.5393659407516214,"['SFRP4', 'TGFB1', 'GADD45A', 'DDIT3', 'NDN']",0.8884034096969826,0,0,5
127,G1 to S cell cycle control WP45,0.3250469764377328,1.5391242937853107,1.7296456628845127,"['GADD45A', 'RPA3', 'POLE2']",0.8884034096969826,0,0,3
128,Spinal Cord Injury WP2431,0.3252976982463179,1.4210526315789473,1.5958627408166077,"['TGFB1', 'GADD45A', 'APEX1', 'TNFSF13B']",0.8884034096969826,0,0,4
129,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.33309109330803,1.7584400934654743,1.93312225384667,"['TGFB1', 'BAX']",0.8884034096969826,0,0,2
130,Nucleotide Excision Repair WP4753,0.3393665874538736,1.497388914338067,1.618189832055201,"['POLE4', 'RPA3', 'POLE2']",0.8884034096969826,0,0,3
131,Serotonin and anxiety-related events WP3944,0.34471691464617266,2.636583011583012,2.8080445820219175,['CRH'],0.8884034096969826,0,0,1
132,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.34471691464617266,2.636583011583012,2.8080445820219175,['TGFB1'],0.8884034096969826,0,0,1
133,Trans-sulfuration pathway WP2333,0.34471691464617266,2.636583011583012,2.8080445820219175,['AHCY'],0.8884034096969826,0,0,1
134,Galanin receptor pathway WP4970,0.34471691464617266,2.636583011583012,2.8080445820219175,['PRKCD'],0.8884034096969826,0,0,1
135,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.34471691464617266,2.636583011583012,2.8080445820219175,['ELOB'],0.8884034096969826,0,0,1
136,Leptin and adiponectin WP3934,0.34471691464617266,2.636583011583012,2.8080445820219175,['LEPR'],0.8884034096969826,0,0,1
137,Mitochondrial CII Assembly WP4920,0.34471691464617266,2.636583011583012,2.8080445820219175,['SDHAF1'],0.8884034096969826,0,0,1
138,T-cell receptor (TCR) signaling pathway WP69,0.3490029006309832,1.3681695277620576,1.4402379199579844,"['TGFB1', 'PRKCD', 'PTK2B', 'CD247']",0.8884034096969826,0,0,4
139,Retinoblastoma gene in cancer WP2446,0.3490029006309832,1.3681695277620576,1.4402379199579844,"['ANLN', 'H2AFZ', 'RPA3', 'POLE2']",0.8884034096969826,0,0,4
140,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.35366559522350205,1.457850133809099,1.515294471156635,"['EIF4A2', 'RPS6KA5', 'PRKCD']",0.8884034096969826,0,0,3
141,DNA damage response WP707,0.35366559522350205,1.457850133809099,1.515294471156635,"['GADD45A', 'CYCS', 'BAX']",0.8884034096969826,0,0,3
142,Modulators of TCR signaling and T cell activation WP5072,0.35366559522350205,1.457850133809099,1.515294471156635,"['NDUFB10', 'ELOB', 'CD247']",0.8884034096969826,0,0,3
143,Bladder cancer WP2828,0.3710339546455203,1.6052379901419849,1.5915319843746596,"['RPS6KA5', 'DAPK2']",0.8884034096969826,0,0,2
144,Oxidative Damage WP3941,0.3710339546455203,1.6052379901419849,1.5915319843746596,"['GADD45A', 'CYCS']",0.8884034096969826,0,0,2
145,15q11.2 copy number variation syndrome WP4940,0.3784538687521045,2.3067989864864864,2.241426823745078,['TUBGCP4'],0.8884034096969826,0,0,1
146,Biomarkers for pyrimidine metabolism disorders WP4584,0.3784538687521045,2.3067989864864864,2.241426823745078,['NT5C'],0.8884034096969826,0,0,1
147,Development and heterogeneity of the ILC family WP3893,0.3784538687521045,2.3067989864864864,2.241426823745078,['IL7'],0.8884034096969826,0,0,1
148,Major receptors targeted by epinephrine and norepinephrine WP4589,0.3784538687521045,2.3067989864864864,2.241426823745078,['ADCY10'],0.8884034096969826,0,0,1
149,Non-homologous end joining WP438,0.3784538687521045,2.3067989864864864,2.241426823745078,['DCLRE1C'],0.8884034096969826,0,0,1
150,Purine metabolism WP4792,0.3784538687521045,2.3067989864864864,2.241426823745078,['PRPS1'],0.8884034096969826,0,0,1
151,Pyrimidine metabolism and related diseases WP4225,0.3784538687521045,2.3067989864864864,2.241426823745078,['NT5C'],0.8884034096969826,0,0,1
152,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3821294671949559,1.3847033898305086,1.3320788569457742,"['DCLRE1C', 'KAT5', 'BAX']",0.8884034096969826,0,0,3
153,miRNA regulation of DNA damage response WP1530,0.3821294671949559,1.3847033898305086,1.3320788569457742,"['GADD45A', 'CYCS', 'BAX']",0.8884034096969826,0,0,3
154,Alpha 6 Beta 4 signaling pathway WP244,0.3896848488906003,1.5382120699379582,1.449637121710562,"['PRKCD', 'GAB1']",0.8884034096969826,0,0,2
155,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3962607508637567,1.3508061182306739,1.2504180203649518,"['IFI27L2', 'PRKCH', 'PRKCD']",0.8884034096969826,0,0,3
156,BDNF-TrkB Signaling WP3676,0.40808494528140477,1.4765482233502538,1.3234005338796018,"['TRPC3', 'GAB1']",0.8884034096969826,0,0,2
157,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.40808494528140477,1.4765482233502538,1.3234005338796018,"['PRKCH', 'PRKCD']",0.8884034096969826,0,0,2
158,Proximal tubule transport WP4917,0.40808494528140477,1.4765482233502538,1.3234005338796018,"['ABCB1', 'SLC3A1']",0.8884034096969826,0,0,2
159,Canonical and non-canonical TGF-B signaling WP3874,0.4104566660350096,2.0503003003003,1.8257614979109618,['TGFB1'],0.8884034096969826,0,0,1
160,Computational Model of Aerobic Glycolysis WP4629,0.4104566660350096,2.0503003003003,1.8257614979109618,['LDHA'],0.8884034096969826,0,0,1
161,Cysteine and methionine catabolism WP4504,0.4104566660350096,2.0503003003003,1.8257614979109618,['AHCY'],0.8884034096969826,0,0,1
162,"GPCRs, Class B Secretin-like WP334",0.4104566660350096,2.0503003003003,1.8257614979109618,['ADGRG2'],0.8884034096969826,0,0,1
163,Hedgehog Signaling Pathway Netpath WP47,0.4104566660350096,2.0503003003003,1.8257614979109618,['GLI3'],0.8884034096969826,0,0,1
164,Kynurenine Pathway and links to Cellular Senescence WP5044,0.4104566660350096,2.0503003003003,1.8257614979109618,['ACMSD'],0.8884034096969826,0,0,1
165,Small cell lung cancer WP4658,0.41989019797666394,1.2306734578381437,1.0679317045304377,"['GADD45A', 'FN1', 'CYCS', 'BAX']",0.8884034096969826,0,0,4
166,Translation Factors WP107,0.4242456679376198,1.2877414268821443,1.1041643392005558,"['EIF4A2', 'EEF1B2', 'EEF1G']",0.8884034096969826,0,0,3
167,Tumor suppressor activity of SMARCB1 WP4204,0.42621067775385896,1.4196277495769882,1.2106890756996032,"['H3F3B', 'GLI3']",0.8884034096969826,0,0,2
168,DNA Replication WP466,0.42621067775385896,1.4196277495769882,1.2106890756996032,"['RPA3', 'POLE2']",0.8884034096969826,0,0,2
169,GABA receptor Signaling WP4159,0.42621067775385896,1.4196277495769882,1.2106890756996032,"['SLC32A1', 'GABRD']",0.8884034096969826,0,0,2
170,Wnt signaling pathway and pluripotency WP399,0.4315652390586405,1.2103871524395335,1.017132610514866,"['PRKCH', 'PRKCD', 'TCF7', 'LDLR']",0.8884034096969826,0,0,4
171,Serotonin and anxiety WP3947,0.44081430317632553,1.8451013513513514,1.5113807731029292,['CRH'],0.8884034096969826,0,0,1
172,BMP Signaling Pathway in Eyelid Development WP3927,0.44081430317632553,1.8451013513513514,1.5113807731029292,['SFRP1'],0.8884034096969826,0,0,1
173,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.44081430317632553,1.8451013513513514,1.5113807731029292,['CCK'],0.8884034096969826,0,0,1
174,TYROBP causal network in microglia WP3945,0.44081430317632553,1.8451013513513514,1.5113807731029292,['LHFPL2'],0.8884034096969826,0,0,1
175,Leptin Insulin Overlap WP3935,0.44081430317632553,1.8451013513513514,1.5113807731029292,['LEPR'],0.8884034096969826,0,0,1
176,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.44081430317632553,1.8451013513513514,1.5113807731029292,['SFRP4'],0.8884034096969826,0,0,1
177,Type 2 papillary renal cell carcinoma WP4241,0.4440415602079413,1.3669236071943347,1.109719320230552,"['TGFB1', 'ELOB']",0.8884034096969826,0,0,2
178,Hedgehog Signaling Pathway WP4249,0.4440415602079413,1.3669236071943347,1.109719320230552,"['HHIP', 'GLI3']",0.8884034096969826,0,0,2
179,Male infertility WP4673,0.4547148265555732,1.171746570727895,0.9234356751386024,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.8884034096969826,0,0,4
180,Osteoblast differentiation WP4787,0.4547148265555732,1.171746570727895,0.9234356751386024,"['PRKCH', 'PRKCD', 'FGF1', 'GLI3']",0.8884034096969826,0,0,4
181,Copper homeostasis WP3286,0.4615599328072512,1.3179840464104424,1.01899062491936,"['COX17', 'ATOX1']",0.8884034096969826,0,0,2
182,Parkinson's disease pathway WP2371,0.4615599328072512,1.3179840464104424,1.01899062491936,"['CYCS', 'UBE2L6']",0.8884034096969826,0,0,2
183,Wnt signaling WP428,0.4661734625816715,1.1533319185059423,0.8802200101395699,"['SFRP4', 'SFRP1', 'TCF7', 'CXXC4']",0.8884034096969826,0,0,4
184,Airway smooth muscle cell contraction WP4962,0.46961121672784345,1.6772113022113022,1.2677203725064163,['MYLK'],0.8884034096969826,0,0,1
185,ERK Pathway in Huntington's Disease WP3853,0.46961121672784345,1.6772113022113022,1.2677203725064163,['RPS6KA5'],0.8884034096969826,0,0,1
186,GDNF/RET signaling axis WP4830,0.46961121672784345,1.6772113022113022,1.2677203725064163,['GLI3'],0.8884034096969826,0,0,1
187,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.46961121672784345,1.6772113022113022,1.2677203725064163,['ABCB1'],0.8884034096969826,0,0,1
188,Phytochemical activity on NRF2 transcriptional activation WP3,0.46961121672784345,1.6772113022113022,1.2677203725064163,['AIMP2'],0.8884034096969826,0,0,1
189,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.46961121672784345,1.6772113022113022,1.2677203725064163,['LDHA'],0.8884034096969826,0,0,1
190,Apoptosis WP254,0.478738668269998,1.177713667508114,0.8675043682024994,"['HRK', 'CYCS', 'BAX']",0.8884034096969826,0,0,3
191,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4787507263367073,1.272419627749577,0.9372327689419676,"['GAB1', 'PTK2B']",0.8884034096969826,0,0,2
192,Target Of Rapamycin (TOR) Signaling WP1471,0.4787507263367073,1.272419627749577,0.9372327689419676,"['RRAGA', 'HMGCR']",0.8884034096969826,0,0,2
193,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.4787507263367073,1.272419627749577,0.9372327689419676,"['MAP1LC3A', 'IGFBP5']",0.8884034096969826,0,0,2
194,Integrated Cancer Pathway WP1971,0.4787507263367073,1.272419627749577,0.9372327689419676,"['BAX', 'BACH1']",0.8884034096969826,0,0,2
195,Nuclear Receptors Meta-Pathway WP2882,0.4849104419658671,1.0577611028706047,0.7655980307578828,"['ABCB1', 'TGFB1', 'B3GNT5', 'AIP', 'BAX', 'SLC39A7', 'CBR3', 'SLC39A3', 'FKBP5']",0.890019433204671,0,0,9
196,Pancreatic adenocarcinoma pathway WP4263,0.48882172775868754,1.1181766733549416,0.8003432518175081,"['TGFB1', 'GADD45A', 'PRKCD', 'BAX']",0.890019433204671,0,0,4
197,Nephrotic syndrome WP4758,0.49560124299079716,1.229892836999436,0.8633646273775496,"['ANLN', 'GPC5']",0.890019433204671,0,0,2
198,Apoptosis Modulation by HSP70 WP384,0.496927516872608,1.537302927927928,1.075053008978426,['CYCS'],0.890019433204671,0,0,1
199,Heart Development WP1591,0.496927516872608,1.537302927927928,1.075053008978426,['VEGFB'],0.890019433204671,0,0,1
200,Kallmann's Syndrome WP5074,0.496927516872608,1.537302927927928,1.075053008978426,['ASCL1'],0.890019433204671,0,0,1
201,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.496927516872608,1.537302927927928,1.075053008978426,['ASCL1'],0.890019433204671,0,0,1
202,Pathways Regulating Hippo Signaling WP4540,0.49999789804930844,1.1013861085067025,0.7634273059476281,"['PRKCH', 'PRKD3', 'PRKCD', 'TCF7']",0.8910853628601537,0,0,4
203,Prader-Willi and Angelman Syndrome WP3998,0.5121009531479574,1.1901097101686589,0.7964612858416018,"['NDN', 'GABRD']",0.908159325779629,0,0,2
204,Vitamin B12 metabolism WP1533,0.5228392081446865,1.4189189189189189,0.920142390233261,['LDLR'],0.9092855793820636,0,0,1
205,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5228392081446865,1.4189189189189189,0.920142390233261,['BAX'],0.9092855793820636,0,0,1
206,Pregnane X receptor pathway WP2876,0.5228392081446865,1.4189189189189189,0.920142390233261,['ABCB1'],0.9092855793820636,0,0,1
207,Purinergic signaling WP4900,0.5228392081446865,1.4189189189189189,0.920142390233261,['P2RY14'],0.9092855793820636,0,0,1
208,Cytosolic DNA-sensing pathway WP4655,0.5282413064911184,1.1528130287648055,0.7357276725875805,"['POLR1C', 'POLR2K']",0.909844920047736,0,0,2
209,Genotoxicity pathway WP4286,0.5282413064911184,1.1528130287648055,0.7357276725875805,"['RPS27', 'GADD45A']",0.909844920047736,0,0,2
210,Constitutive Androstane Receptor Pathway WP2875,0.5474183999841506,1.3174469111969112,0.793816924871275,['ABCB1'],0.909844920047736,0,0,1
211,Gastric Cancer Network 1 WP2361,0.5474183999841506,1.3174469111969112,0.793816924871275,['KIF15'],0.909844920047736,0,0,1
212,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5474183999841506,1.3174469111969112,0.793816924871275,['MYLK'],0.909844920047736,0,0,1
213,NRF2 pathway WP2884,0.554165357009542,1.0244293529522732,0.604712613896939,"['TGFB1', 'SLC39A7', 'SLC39A3', 'CBR3']",0.909844920047736,0,0,4
214,Metabolic reprogramming in colon cancer WP4290,0.5594185991835624,1.0848014332636609,0.630114777664239,"['LDHA', 'PGAM1']",0.909844920047736,0,0,2
215,Endoderm differentiation WP2853,0.5631721681626914,1.0020149364093462,0.5753268085060669,"['DUSP4', 'SFRP1', 'TGFB1', 'TCF7', 'PBX3']",0.909844920047736,0,0,5
216,DNA damage response (only ATM dependent) WP710,0.5646212300958375,1.0103030443984464,0.5774893837037113,"['TGFB1', 'TCF7', 'BAX', 'LDLR']",0.909844920047736,0,0,4
217,Non-small cell lung cancer WP4255,0.567700010785167,1.0243879472693032,0.579969682462832,"['GADD45A', 'CYCS', 'BAX']",0.909844920047736,0,0,3
218,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5707335057931756,1.2295045045045045,0.6895465684262432,['FGF1'],0.909844920047736,0,0,1
219,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5707335057931756,1.2295045045045045,0.6895465684262432,['BAX'],0.909844920047736,0,0,1
220,Immune response to tuberculosis WP4197,0.5707335057931756,1.2295045045045045,0.6895465684262432,['IFIT3'],0.909844920047736,0,0,1
221,Nucleotide metabolism WP404,0.5707335057931756,1.2295045045045045,0.6895465684262432,['PRPS1'],0.909844920047736,0,0,1
222,Pre-implantation embryo WP3527,0.5707335057931756,1.2295045045045045,0.6895465684262432,['DDIT3'],0.909844920047736,0,0,1
223,Proteoglycan biosynthesis WP4784,0.5707335057931756,1.2295045045045045,0.6895465684262432,['PAPSS2'],0.909844920047736,0,0,1
224,SARS-CoV-2 mitochondrial interactions WP5038,0.5707335057931756,1.2295045045045045,0.6895465684262432,['NDUFB9'],0.909844920047736,0,0,1
225,7-oxo-C and 7beta-HC pathways WP5064,0.5928494321236314,1.1525548986486487,0.6025727829764314,['DHCR7'],0.909844920047736,0,0,1
226,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5928494321236314,1.1525548986486487,0.6025727829764314,['H3F3B'],0.909844920047736,0,0,1
227,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5928494321236314,1.1525548986486487,0.6025727829764314,['ANGPT2'],0.909844920047736,0,0,1
228,NAD+ biosynthetic pathways WP3645,0.5928494321236314,1.1525548986486487,0.6025727829764314,['ACMSD'],0.909844920047736,0,0,1
229,Purine metabolism and related disorders WP4224,0.5928494321236314,1.1525548986486487,0.6025727829764314,['PRPS1'],0.909844920047736,0,0,1
230,DNA Repair Pathways Full Network WP4946,0.5994543809595019,0.9599100056689343,0.49121993316923135,"['POLE4', 'DCLRE1C', 'RPA3', 'POLE2', 'APEX1']",0.909844920047736,0,0,5
231,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6033709740893154,0.9965701742351488,0.5034902302840126,"['TGFB1', 'TCF7']",0.909844920047736,0,0,2
232,Eukaryotic Transcription Initiation WP405,0.6033709740893154,0.9965701742351488,0.5034902302840126,"['POLR2I', 'POLR2K']",0.909844920047736,0,0,2
233,Histone Modifications WP2369,0.6033709740893154,0.9965701742351488,0.5034902302840126,"['SET', 'H3F3B']",0.909844920047736,0,0,2
234,Hepatitis B infection WP4666,0.6082559725854236,0.9499263622974963,0.47226489448757225,"['TGFB1', 'ATP6AP1', 'CYCS', 'PTK2B', 'BAX']",0.909844920047736,0,0,5
235,16p11.2 distal deletion syndrome WP4950,0.613827758190641,1.0846581875993642,0.5293575735884357,['CD81'],0.909844920047736,0,0,1
236,1q21.1 copy number variation syndrome WP4905,0.613827758190641,1.0846581875993642,0.5293575735884357,['FMO5'],0.909844920047736,0,0,1
237,Trans-sulfuration and one-carbon metabolism WP2525,0.613827758190641,1.0846581875993642,0.5293575735884357,['AHCY'],0.909844920047736,0,0,1
238,Tryptophan metabolism WP465,0.613827758190641,1.0846581875993642,0.5293575735884357,['ACMSD'],0.909844920047736,0,0,1
239,White fat cell differentiation WP4149,0.613827758190641,1.0846581875993642,0.5293575735884357,['DDIT3'],0.909844920047736,0,0,1
240,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.613827758190641,1.0846581875993642,0.5293575735884357,['LDHA'],0.909844920047736,0,0,1
241,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.613827758190641,1.0846581875993642,0.5293575735884357,['MAP1LC3A'],0.909844920047736,0,0,1
242,Oxidation by Cytochrome P450 WP43,0.613827758190641,1.0846581875993642,0.5293575735884357,['CYB5R1'],0.909844920047736,0,0,1
243,MECP2 and Associated Rett Syndrome WP3584,0.6141453210322219,0.9533898305084746,0.464800137362472,"['SST', 'OPRK1', 'FKBP5']",0.909844920047736,0,0,3
244,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6307838861473418,0.9452904681331077,0.43558225639540243,"['ADCY10', 'TGFB1']",0.9236505512644314,0,0,2
245,p53 transcriptional gene network WP4963,0.6307838861473418,0.9452904681331077,0.43558225639540243,"['GADD45A', 'BAX']",0.9236505512644314,0,0,2
246,Glycerolipids and Glycerophospholipids WP4722,0.6337269060064293,1.0243055555555556,0.46722383217131186,['CDIPT'],0.9236505512644314,0,0,1
247,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6337269060064293,1.0243055555555556,0.46722383217131186,['TRPC3'],0.9236505512644314,0,0,1
248,Phosphodiesterases in neuronal function WP4222,0.6439267864806792,0.9215736040609137,0.40564927902004266,"['ADCY10', 'PDE5A']",0.9347324319880828,0,0,2
249,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.652602302281463,0.9703058321479374,0.41411427125717815,['TGFB1'],0.9360033020769988,0,0,1
250,Glycosylation and related congenital defects WP4521,0.652602302281463,0.9703058321479374,0.41411427125717815,['DPM3'],0.9360033020769988,0,0,1
251,NRF2-ARE regulation WP4357,0.652602302281463,0.9703058321479374,0.41411427125717815,['AIMP2'],0.9360033020769988,0,0,1
252,Pathways in clear cell renal cell carcinoma WP4018,0.6571126077936059,0.8915527610716238,0.37436289581688553,"['LDHA', 'TGFB1', 'ALDOC']",0.93813130839288,0,0,3
253,Calcium Regulation in the Cardiac Cell WP536,0.6666238412505406,0.8854166666666666,0.3590624438034933,"['PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ATP1B2']",0.93813130839288,0,0,5
254,B Cell Receptor Signaling Pathway WP23,0.6673000482244114,0.8773204196933011,0.354889696655866,"['CD81', 'PRKCD', 'GAB1']",0.93813130839288,0,0,3
255,Corticotropin-releasing hormone signaling pathway WP2355,0.6673000482244114,0.8773204196933011,0.354889696655866,"['TGFB1', 'PRKCD', 'CRH']",0.93813130839288,0,0,3
256,Nanoparticle triggered autophagic cell death WP2509,0.670506531496175,0.9217060810810811,0.3684260461301357,['MAP1LC3A'],0.93813130839288,0,0,1
257,Insulin Signaling WP481,0.6796363190980658,0.8766934371704389,0.3385767687602186,"['XBP1', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1']",0.93813130839288,0,0,6
258,AGE/RAGE pathway WP2324,0.6811360673296565,0.857041671585409,0.3290981633849464,"['PRKCD', 'CYCS']",0.93813130839288,0,0,2
259,Regulation of Actin Cytoskeleton WP51,0.6822147401357955,0.8685502502887947,0.3321429981940886,"['CHRM5', 'FN1', 'FGF1', 'MYLK', 'ACTG1']",0.93813130839288,0,0,5
260,Glioblastoma signaling pathways WP2261,0.6870076470112865,0.8501694915254238,0.3191620062199192,"['PRKCH', 'PRKCD', 'GAB1']",0.93813130839288,0,0,3
261,Ethanol effects on histone modifications WP3996,0.6874894813866077,0.8777348777348777,0.3288949383054706,['AHCY'],0.93813130839288,0,0,1
262,Synaptic Vesicle Pathway WP2267,0.6928128917282685,0.8374865405322258,0.30735363570756774,"['SLC32A1', 'CPLX3']",0.93813130839288,0,0,2
263,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6928128917282685,0.8374865405322258,0.30735363570756774,"['FN1', 'MYLK']",0.93813130839288,0,0,2
264,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6928128917282685,0.8374865405322258,0.30735363570756774,"['TGFB1', 'FAT1']",0.93813130839288,0,0,2
265,Focal Adhesion WP306,0.6936063917023778,0.862835391822828,0.31566887884715134,"['RELN', 'SHC3', 'FN1', 'VEGFB', 'MYLK', 'ACTG1']",0.93813130839288,0,0,6
266,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6965286788470927,0.837211093990755,0.30277430362826285,"['SHC3', 'GAB1', 'BAX']",0.93813130839288,0,0,3
267,MAPK Signaling Pathway WP382,0.7026076046200943,0.8658019105077929,0.3055905987516655,"['DUSP4', 'RPS6KA5', 'TGFB1', 'GADD45A', 'DDIT3', 'PRKCD', 'HSPB1', 'FGF1']",0.93813130839288,0,0,8
268,Sphingolipid pathway WP1422,0.70359848129466,0.8377610565110565,0.2945127418461134,['SERINC1'],0.93813130839288,0,0,1
269,IL17 signaling pathway WP2112,0.70359848129466,0.8377610565110565,0.2945127418461134,['TRAF3IP2'],0.93813130839288,0,0,1
270,Neovascularisation processes WP4331,0.70359848129466,0.8377610565110565,0.2945127418461134,['TGFB1'],0.93813130839288,0,0,1
271,Pathways affected in adenoid cystic carcinoma WP3651,0.7151070733218078,0.8009269476936659,0.26856922255835336,"['MYCBP', 'FOXP2']",0.9446875556754856,0,0,2
272,Signal transduction through IL1R WP4496,0.7188784329313991,0.8012632197414806,0.2644673529448318,['TGFB1'],0.9446875556754856,0,0,1
273,The influence of laminopathies on Wnt signaling WP4844,0.7188784329313991,0.8012632197414806,0.2644673529448318,['TCF7'],0.9446875556754856,0,0,1
274,Integrated breast cancer pathway WP1984,0.7190121951530085,0.829043329043329,0.27348229320509687,"['GADD45A', 'BAX', 'HMGCR', 'FAU', 'BACH1']",0.9446875556754856,0,0,5
275,Glycerophospholipid Biosynthetic Pathway WP2533,0.7333719347691415,0.7678068693693694,0.23809866951924857,['CDIPT'],0.95032087865808,0,0,1
276,Melatonin metabolism and effects WP3298,0.7333719347691415,0.7678068693693694,0.23809866951924857,['PER2'],0.95032087865808,0,0,1
277,AMP-activated protein kinase (AMPK) signaling WP1403,0.7459881965354099,0.7516834144825443,0.22027744297244295,"['LEPR', 'HMGCR']",0.95032087865808,0,0,2
278,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7459881965354099,0.7516834144825443,0.22027744297244295,"['TCF7', 'ACTG1']",0.95032087865808,0,0,2
279,Complement system WP2806,0.7471193999495969,0.737027027027027,0.21486568622032123,['RPS19'],0.95032087865808,0,0,1
280,Nanoparticle-mediated activation of receptor signaling WP2643,0.7471193999495969,0.737027027027027,0.21486568622032123,['FN1'],0.95032087865808,0,0,1
281,Chemokine signaling pathway WP3929,0.7494349477617677,0.7830798685113608,0.22586823653454877,"['SHC3', 'PRKCD', 'PTK2B', 'CXCL14']",0.95032087865808,0,0,4
282,miRNA regulation of prostate cancer signaling pathways WP3981,0.7601591682298623,0.7086148648648649,0.19432163732491906,['TCF7'],0.95032087865808,0,0,1
283,Prion disease pathway WP3995,0.7601591682298623,0.7086148648648649,0.19432163732491906,['HSPA5'],0.95032087865808,0,0,1
284,G Protein Signaling Pathways WP35,0.764882682134578,0.7461520842876775,0.19999324252719475,"['PRKCH', 'PRKD3', 'PRKCD']",0.95032087865808,0,0,3
285,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.765271703565085,0.7793583535108959,0.2084973292664413,"['LINGO1', 'RPS6KA5', 'SHC3', 'PRKCD', 'PTK2B']",0.95032087865808,0,0,5
286,ATM Signaling Pathway WP2516,0.7725276122845591,0.6823073073073073,0.1760950054546143,['GADD45A'],0.95032087865808,0,0,1
287,"GPCRs, Other WP117",0.7725276122845591,0.6823073073073073,0.1760950054546143,['ADGRV1'],0.95032087865808,0,0,1
288,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7725276122845591,0.6823073073073073,0.1760950054546143,['SUPT4H1'],0.95032087865808,0,0,1
289,Melanoma WP4685,0.7739539123619065,0.7081218274111675,0.18145122737293012,"['GADD45A', 'BAX']",0.95032087865808,0,0,2
290,MET in type 1 papillary renal cell carcinoma WP4205,0.7739539123619065,0.7081218274111675,0.18145122737293012,"['RPL11', 'GAB1']",0.95032087865808,0,0,2
291,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7826604756314579,0.694697187370303,0.17023992021410533,"['HSPA5', 'UBE2L6']",0.95032087865808,0,0,2
292,CAMKK2  Pathway WP4874,0.7842592383287579,0.657878861003861,0.15987486044548263,['MAP1LC3A'],0.95032087865808,0,0,1
293,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7842592383287579,0.657878861003861,0.15987486044548263,['TGFB1'],0.95032087865808,0,0,1
294,Head and Neck Squamous Cell Carcinoma WP4674,0.791071391075361,0.6817697562198408,0.15978437410062152,"['GAB1', 'FAT1']",0.95032087865808,0,0,2
295,Amyotrophic lateral sclerosis (ALS) WP2447,0.7953867818060567,0.6351351351351351,0.14539943159838944,['BAX'],0.95032087865808,0,0,1
296,Ferroptosis WP4313,0.7953867818060567,0.6351351351351351,0.14539943159838944,['MAP1LC3A'],0.95032087865808,0,0,1
297,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7953867818060567,0.6351351351351351,0.14539943159838944,['DDIT3'],0.95032087865808,0,0,1
298,IL-2 signaling pathway WP49,0.7953867818060567,0.6351351351351351,0.14539943159838944,['PTK2B'],0.95032087865808,0,0,1
299,Vitamin D-sensitive calcium signaling in depression WP4698,0.8059412981936849,0.6139076576576576,0.1324471209334681,['PVALB'],0.95032087865808,0,0,1
300,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8059412981936849,0.6139076576576576,0.1324471209334681,['ACTG1'],0.95032087865808,0,0,1
301,Netrin-UNC5B signaling pathway WP4747,0.8059412981936849,0.6139076576576576,0.1324471209334681,['PTK2B'],0.95032087865808,0,0,1
302,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8059412981936849,0.6139076576576576,0.1324471209334681,['TGFB1'],0.95032087865808,0,0,1
303,Alzheimer's disease WP2059,0.814603530963568,0.6457090272211833,0.1324050569105407,"['ATP5MD', 'CYCS']",0.95032087865808,0,0,2
304,Aryl Hydrocarbon Receptor Netpath WP2586,0.8159522487634723,0.5940496948561464,0.12082937788123249,['AIP'],0.95032087865808,0,0,1
305,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8159522487634723,0.5940496948561464,0.12082937788123249,['GABRD'],0.95032087865808,0,0,1
306,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8159522487634723,0.5940496948561464,0.12082937788123249,['CYCS'],0.95032087865808,0,0,1
307,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8159522487634723,0.5940496948561464,0.12082937788123249,['BAX'],0.95032087865808,0,0,1
308,Circadian rhythm related genes WP3594,0.8159759143405066,0.7235256307247309,0.1471437267351005,"['PER2', 'AHCY', 'CRH', 'RPS27A', 'HCRTR2']",0.95032087865808,0,0,5
309,16p11.2 proximal deletion syndrome WP4949,0.8219052029655907,0.6345177664974619,0.1244481062409637,"['SEZ6L2', 'CDIPT']",0.95032087865808,0,0,2
310,TGF-beta Receptor Signaling WP560,0.8254475828002182,0.5754328547297297,0.11038500552671587,['TGFB1'],0.95032087865808,0,0,1
311,IL-3 signaling pathway WP286,0.8254475828002182,0.5754328547297297,0.11038500552671587,['TGFB1'],0.95032087865808,0,0,1
312,One-carbon metabolism and related pathways WP3940,0.8254475828002182,0.5754328547297297,0.11038500552671587,['CHDH'],0.95032087865808,0,0,1
313,Gastrin signaling pathway WP4659,0.8262512083888306,0.6646926689810088,0.1268608667377812,"['PRKCH', 'KAT5', 'PRKCD']",0.95032087865808,0,0,3
314,Glycogen Synthesis and Degradation WP500,0.8344538146035908,0.5579443079443079,0.10097557935142694,['PHKG1'],0.956698640946792,0,0,1
315,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8422853579083418,0.6031455438129317,0.10352174023593451,"['TGFB1', 'MYLK']",0.9603753007048308,0,0,2
316,Interleukin-11 Signaling Pathway WP2332,0.8429960972853514,0.5414844992050875,0.09248173529402,['TGFB1'],0.9603753007048308,0,0,1
317,Pathogenic Escherichia coli infection WP2272,0.8510982925082867,0.5259652509652509,0.08480014387667724,['ACTG1'],0.9631211624562255,0,0,1
318,Leptin signaling pathway WP2034,0.8546732365568321,0.5838906346520559,0.09169188623156711,"['LEPR', 'BAX']",0.9631211624562255,0,0,2
319,PI3K-Akt signaling pathway WP4172,0.8568237961591862,0.7095959119793336,0.10964887983891608,"['RELN', 'ANGPT2', 'IL7', 'FN1', 'VEGFB', 'COL6A6', 'FGF1']",0.9631211624562255,0,0,7
320,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8587830365234678,0.5113081831831832,0.07784102896532427,['TGFB1'],0.9631211624562255,0,0,1
321,Common Pathways Underlying Drug Addiction WP2636,0.8587830365234678,0.5113081831831832,0.07784102896532427,['ACTG1'],0.9631211624562255,0,0,1
322,Glucocorticoid Receptor Pathway WP2880,0.8660718033789279,0.4974433893352812,0.07152612145844059,['B3GNT5'],0.9652812669238824,0,0,1
323,RANKL/RANK signaling pathway WP2018,0.8660718033789279,0.4974433893352812,0.07152612145844059,['PAPSS2'],0.9652812669238824,0,0,1
324,IL-4 signaling pathway WP395,0.872984964086061,0.48430832147937414,0.06578696358334442,['HRH1'],0.9668408738020887,0,0,1
325,Exercise-induced Circadian Regulation WP410,0.8795418433123203,0.47184684684684686,0.06056349609045226,['PER2'],0.9668408738020887,0,0,1
326,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8795418433123203,0.47184684684684686,0.06056349609045226,['MAP1LC3A'],0.9668408738020887,0,0,1
327,Regulation of Microtubule Cytoskeleton WP2038,0.8795418433123203,0.47184684684684686,0.06056349609045226,['PARD6A'],0.9668408738020887,0,0,1
328,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8857607732931991,0.4600084459459459,0.055802875870447265,['RPS6KA5'],0.9668408738020887,0,0,1
329,TGF-beta Signaling Pathway WP366,0.8863764319311679,0.5800892060660124,0.06996661954385527,"['TGFB1', 'PARD6A', 'FN1']",0.9668408738020887,0,0,3
330,22q11.2 copy number variation syndrome WP4657,0.8913453486878824,0.5251631617113851,0.06040601558820283,"['MRPL40', 'RELN']",0.9668408738020887,0,0,2
331,ESC Pluripotency Pathways WP3931,0.8913453486878824,0.5251631617113851,0.06040601558820283,"['GAB1', 'FGF1']",0.9668408738020887,0,0,2
332,Cardiac Hypertrophic Response WP2795,0.9025593493379349,0.42779698302954117,0.04385810172804934,['TGFB1'],0.9668408738020887,0,0,1
333,Interferon type I signaling pathways WP585,0.9025593493379349,0.42779698302954117,0.04385810172804934,['RPS6KA5'],0.9668408738020887,0,0,1
334,Cell cycle WP179,0.9082433638513722,0.4965930397402479,0.04779356143002682,"['TGFB1', 'GADD45A']",0.9668408738020887,0,0,2
335,ErbB signaling pathway WP673,0.9082433638513722,0.4965930397402479,0.04779356143002682,"['SHC3', 'GAB1']",0.9668408738020887,0,0,2
336,Androgen receptor signaling pathway WP138,0.9120663019160862,0.4899266779469825,0.04509412136782031,"['KAT5', 'ETV5']",0.9668408738020887,0,0,2
337,Ectoderm Differentiation WP2858,0.9121683957252649,0.5399302093718843,0.049636141320512354,"['MAFB', 'PTPN13', 'GLI3']",0.9668408738020887,0,0,3
338,7q11.23 copy number variation syndrome WP4932,0.9157396036241563,0.48343574672722417,0.04255357604110887,"['UBE2L6', 'ATP5MC1']",0.9668408738020887,0,0,2
339,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9184938513687637,0.5294491525423729,0.04501380324747526,"['SLCO1C1', 'RPS6KA5', 'SHC3']",0.9668408738020887,0,0,3
340,EGF/EGFR signaling pathway WP437,0.9193447179030869,0.564346349745331,0.04745821296850535,"['RPS6KA5', 'PRKCD', 'GAB1', 'PTK2B']",0.9668408738020887,0,0,4
341,3q29 copy number variation syndrome WP4906,0.9211844992058791,0.39124496837262795,0.03211923138948285,['TGFB1'],0.9668408738020887,0,0,1
342,Neural Crest Differentiation WP2064,0.9211844992058791,0.39124496837262795,0.03211923138948285,['ASCL1'],0.9668408738020887,0,0,1
343,Rett syndrome causing genes WP4312,0.9211844992058791,0.39124496837262795,0.03211923138948285,['GABRD'],0.9668408738020887,0,0,1
344,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.928640387330672,0.6004412545033094,0.044452894687804764,"['RELN', 'ANGPT2', 'COL5A1', 'FN1', 'VEGFB', 'FGF1']",0.971832963485587,0,0,6
345,Thermogenesis WP4321,0.9403388216033647,0.4370719523003787,0.026886489952683088,"['ADCY10', 'ACTG1']",0.9782087489983337,0,0,2
346,Ciliopathies WP4803,0.9409101665378522,0.5273662224719375,0.03212061615661765,"['MAK', 'CCDC65', 'CCDC28B', 'GLI3']",0.9782087489983337,0,0,4
347,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9428845441733938,0.43189011645267245,0.025400078997957286,"['TGFB1', 'FN1']",0.9782087489983337,0,0,2
348,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9456363229806339,0.34030905905905906,0.019022330492114995,['APEX1'],0.9782444720489317,0,0,1
349,Mesodermal commitment pathway WP2857,0.952071105025366,0.41232723055571396,0.020251681523780537,"['PBX3', 'RPL38']",0.9820790768169964,0,0,2
350,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9604659867487859,0.30610923423423425,0.012347439234165746,['SLCO1C1'],0.9843859192707148,0,0,1
351,Amino Acid metabolism WP3925,0.9625106766202546,0.3010633584404076,0.011503667140692907,['LDHA'],0.9843859192707148,0,0,1
352,DNA IR-damage and cellular response via ATR WP4016,0.9625106766202546,0.3010633584404076,0.011503667140692907,['ABRAXAS1'],0.9843859192707148,0,0,1
353,Joubert Syndrome WP4656,0.9696866031094362,0.28243243243243243,0.008693933779545943,['KAT5'],0.9849347068984525,0,0,1
354,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9706148215504203,0.3665989847715736,0.010934024277736648,"['SST', 'ASCL1']",0.9849347068984525,0,0,2
355,TNF-alpha signaling pathway WP231,0.9712550581915296,0.2781275593775594,0.008111915510122093,['BAX'],0.9849347068984525,0,0,1
356,Metapathway biotransformation Phase I and II WP702,0.9779622969217916,0.2584221545489151,0.005758720870838976,['FMO5'],0.9876308852021037,0,0,1
357,Integrin-mediated Cell Adhesion WP185,0.9801849683419287,0.25129581636430953,0.005029429925595454,['SHC3'],0.9876308852021037,0,0,1
358,Fragile X Syndrome  WP4549,0.9821440469509809,0.3299339949086142,0.0059445178074552995,"['GAB1', 'GABRD']",0.9876308852021037,0,0,2
359,Ras signaling WP4223,0.993238567742162,0.27690611700763984,0.0018786402828777885,"['SHC3', 'GAB1']",0.9960052489893546,0,0,2
360,Ciliary landscape WP4352,0.9994619734235048,0.19660675904330727,0.00010580812782933532,"['DOCK5', 'COPS7A']",0.9994619734235048,0,0,2
